Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading causes of death in patients who suffer from it. Indeed, ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

Please provide your email address to receive an email when new articles are posted on . CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every ...

Detection of certain auto-antibodies flagged patients with scleroderma (also known as systemic sclerosis) who were especially likely to develop pulmonary hypertension over long-term follow-up, a ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

Scleroderma-related PAH remains a syndrome that is difficult to treat with currently available medical therapy, for reasons that are poorly understood. Although classified within the group 1 (PAH) of ...

Please provide your email address to receive an email when new articles are posted on . Interstitial lung disease and pulmonary arterial hypertension associated with scleroderma often require ...

Systemic sclerosis (SSc), also known as scleroderma, is characterized by the formation of fibrosis, or scar tissue, on internal organs as well as the skin. Beyond its disfiguring symptoms, SSc is ...

Bosentan has been approved for the treatment of pulmonary arterial hypertension (PAH); however, no extensive analysis of the effect of bosentan on the subset of patients with PAH associated with ...

Researchers found a unique immune cell plays a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis. After injecting mice with ...